N (%) | FINDRISCa prevalence, % (95% CI) | ||
---|---|---|---|
≥ 11 | ≥ 15 | ||
All (95% CI) | 1272 (100.0) | 32.8 (30.3–35.4) | 10.0 (8.6–11.9) |
By groups | |||
Sex | |||
Men | 579 (45.5) | 32.3 (28.6–36.2) | 9.7 (7.5–12.4) |
Women | 693 (54.5) | 33.2 (29.8–36.8) | 10.5 (8.5–13.1) |
Age categories | |||
All | |||
18–39 | 321 (25.2) | 7.8 (5.3–11.3) | 0.9 (0.3–2.9) |
40–59 | 445 (35.0) | 32.1 (28.0–36.6) | 8.3 (6.1–11.3) |
60–75 | 428 (33.7) | 47.4 (42.7–52.2) | 16.8 (13.6–20.7) |
76–80 | 78 (6.1) | 59.0 (47.8–69.3) | 21.8 (14.0–32.3) |
Men | |||
18–39 | 105 (31.2) | 5.7 (2.6–12.2) | 9.5 (1.3–6.5) |
40–59 | 195 (33.7) | 27.7 (21.9–34.4) | 5.1 (2.8–9.3) |
60–75 | 236 (40.8) | 44.9 (38.7–51.3) | 16.1 (11.9–21.4) |
76–80 | 43 (7.4) | 48.8 (34.4–63.5) | 16.3 (8.0–30.4) |
Women | |||
18–39 | 216 (31.2) | 8.8 (5.7–13.4) | 0.9 (0.2–3.6) |
40–59 | 250 (27.7) | 35.6 (29.9–41.7) | 10.8 (7.5–15.3) |
60–75 | 192 (27.7) | 50.5 (43.5–57.5) | 17.7 (12.9–23.8) |
76–80 | 35 (5.1) | 71.4 (54.5–83.9) | 28.6 (16.1–45.5) |